An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice
- PMID: 11104196
- DOI: 10.1002/1531-8257(200011)15:6<1132::aid-mds1011>3.0.co;2-o
An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice
Abstract
Seven patients with Parkinson's disease were implanted with deep brain stimulators to provide chronic electrical stimulation to the subthalamic nucleus bilaterally. Acoustic recordings and neurologic assessments were undertaken before surgery in the medication-off and medication-on conditions and after surgery with and without electrical stimulation in the medication-off and medication-on conditions. The data showed significant improvements in limb motor performance in response to medication before surgery and when the subthalamic nucleus was stimulated after surgery. Six months after surgery, there were small but statistically significant increases in sound pressure level and fundamental frequency variability in response to stimulation in the medication-on condition. No other statistically significant speech changes were measured. These findings are consistent with several other studies that have reported disparity between limb and speech improvements after neurosurgical intervention for Parkinson's disease.
Similar articles
-
Postoperative management of subthalamic nucleus stimulation for Parkinson's disease.Mov Disord. 2002;17 Suppl 3:S188-97. doi: 10.1002/mds.10163. Mov Disord. 2002. PMID: 11948776 Review.
-
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease.Med J Aust. 2002 Aug 5;177(3):142-6. doi: 10.5694/j.1326-5377.2002.tb04700.x. Med J Aust. 2002. PMID: 12149083 Clinical Trial.
-
Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.J Neurosurg. 2001 Aug;95(2):213-21. doi: 10.3171/jns.2001.95.2.0213. J Neurosurg. 2001. PMID: 11780890 Clinical Trial.
-
Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.N Engl J Med. 2003 Nov 13;349(20):1925-34. doi: 10.1056/NEJMoa035275. N Engl J Med. 2003. PMID: 14614167
-
[Speech and voice disorders in Parkinson's disease].Rev Neurol. 2010 Nov 1;51(9):542-50. Rev Neurol. 2010. PMID: 20979034 Review. Spanish.
Cited by
-
Impact of subthalamic nucleus stimulation on the initiation of gait in Parkinson's disease.Exp Brain Res. 2006 Jul;172(4):519-32. doi: 10.1007/s00221-006-0360-7. Epub 2006 Mar 23. Exp Brain Res. 2006. PMID: 16555105 Clinical Trial.
-
Speech Intelligibility During Clinical and Low Frequency.Brain Sci. 2020 Jan 2;10(1):26. doi: 10.3390/brainsci10010026. Brain Sci. 2020. PMID: 31906549 Free PMC article.
-
Pink1 -/- Rats Show Early-Onset Swallowing Deficits and Correlative Brainstem Pathology.Dysphagia. 2018 Dec;33(6):749-758. doi: 10.1007/s00455-018-9896-5. Epub 2018 Apr 30. Dysphagia. 2018. PMID: 29713896 Free PMC article.
-
Effect of LSVT on Lexical Tone in Speakers with Parkinson's Disease.Parkinsons Dis. 2011;2011:897494. doi: 10.4061/2011/897494. Epub 2011 Aug 23. Parkinsons Dis. 2011. PMID: 21876841 Free PMC article.
-
Effects of speech rate modifications on phonatory acoustic outcomes in Parkinson's disease.Front Hum Neurosci. 2024 Feb 21;18:1331816. doi: 10.3389/fnhum.2024.1331816. eCollection 2024. Front Hum Neurosci. 2024. PMID: 38450224 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical